جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

نسخة أوليةمفتوح (مستودع)2020

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals: Retrospective Cohort Study

Research Square

Abstract Background: The uncertainty about COVID-19 outcomes in angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) users continues with contradictory findings. The aim of this study was to determine the effect of ACEI/ARB use in patients with severe COVID-19. Methods: This retrospective cohort study was done in two Saudi public specialty hospitals designated as COVID-19 referral facilities. We included 354 patients with confirmed diagnosis of COVID-19 between April and June 2020, of which 146 were ACEI/ARB users and 208 were non-ACEI/ARB users. Controlling for confounders, we conducted a multivariate logistic regression and a sensitivity analyses using propensity score matching (PSM) and Inverse propensity score weighting (IPSW) for high risk patient subsets. Results: Compared to non-ACEI/ARB users, ACEI/ARB users had an eight-fold higher risk of developing critical or severe COVID-19 (OR=8.25, 95%CI=3.32-20.53); a nearly 7-fold higher risk of intensive care unit (ICU) admission (OR=6.76, 95%CI=2.88-15.89) and a nearly 5-fold higher risk of requiring noninvasive ventilation (OR=4.77,95%CI=2.15-10.55). Patients with diabetes, hypertension, and/or renal disease had a five-fold higher risk of severe COVID-19 disease (OR=5.40,95%CI=2.0-14.54]. These results were confirmed in the PSM and IPSW analyses. Conclusion: In general, but especially among patients with hypertension, diabetes, and/or renal disease, ACEI/ARB use is associated with a significantly higher risk of severe or critical COVID-19 disease, and ICU care.

COVID-19 pandemicACE inhibitorsangiotensin receptor blockerssevere COVID-19
نسخة أوليةمفتوح (مستودع)2020

Prioritization of Human physiology Topics for medical school, what to teach? Expert Teachers' views

—

Abstract Background: There has been a sustained increase in physiology knowledge in the last century that created a growing problem for educationalists and we lack general agreement on the educational content of the physiology course for medical students. Methods: This was a descriptive cross-sectional study that involved physiology teachers with different categories of academic ranking including associate professors, assistant professors, and lecturers who were working at physiology departments in different faculties of medicine on the date of the study. A standardized self-administered questionnaire was developed, pre-tested, and used for data collection from the study population. The collected data was analyzed by the use of computerized statistical package Statistical Package for the Social Sciences (SPSS) version 23.0.Results: The respondents were asked to determine the importance of the topics using three criteria: frequency of encounter, burden, and seriousness, then based on the total score; topics were divided into core (need to know), recommended (good to know), proposed (nice to know). All the contents of physiology subjects were listed and topics were prioritized accordingly. Finally, we established a list of 53 core (need to know) topics. There was no significant correlation found between the current academic status of the participants and Important of the topics. These findings provided evidence of the presence of general agreement among physiologists on the core physiology educational content that need to be taught to medical students.

human physiology educationmedical curriculumtopic prioritizationmedical students